Sixty patients with osteoarthritis of the column, hip or knee, rheumatoid arthritis, musculoskeletal disorders, entered an open study to evaluate the efficacy and tolerance of a new anti-inflammatory drug, isoxicam, 200 mg once daily per os or 300 mg suppositories once a day. Both treatments reduced the severity of the clinical symptoms of the diseases and the drug was well tolerated. No patient showed adverse effects.
Marcolongo, R., Giordano, N., Fioravanti, A. (1984). Evaluation of the efficacy and tolerability of a new non-steroid anti-inflammatory agent, isoxicam [Valutazione dell'efficacia e della tollerabilità di un nuovo antiflogistico non steroideo, l'isoxicam]. LA CLINICA TERAPEUTICA, 111(6), 513-519.
Evaluation of the efficacy and tolerability of a new non-steroid anti-inflammatory agent, isoxicam [Valutazione dell'efficacia e della tollerabilità di un nuovo antiflogistico non steroideo, l'isoxicam]
Giordano N.;
1984-01-01
Abstract
Sixty patients with osteoarthritis of the column, hip or knee, rheumatoid arthritis, musculoskeletal disorders, entered an open study to evaluate the efficacy and tolerance of a new anti-inflammatory drug, isoxicam, 200 mg once daily per os or 300 mg suppositories once a day. Both treatments reduced the severity of the clinical symptoms of the diseases and the drug was well tolerated. No patient showed adverse effects.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/42820
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo